Life Scientist > Health & Medical

Tocovite claims its technology delivers

27 May, 2002 by Melissa Trudinger

Melbourne-based company Tocovite claims an absorption system that it has developed could improve drug delivery through the skin.


US man first to receive Sirtex cancer treatment

24 May, 2002 by Iain Scott

Anti-cancer treatment SIR-Spheres, designed by Sydney-based company Sirtex, has been used on a patient for the first time since it received US Food and Drug Administration (FDA) approval in March this year.


Diabetes research offensive launched

24 May, 2002 by Tanya Hollis

A research and development agreement with the aim of finding an effective treatment for type II diabetes has been signed in Melbourne.


Melbourne researchers discover heart attack gene link

24 May, 2002 by Melissa Trudinger

Australian researchers have determined three genetic loci which are linked to heart attacks.


UQ researchers in bone growth breakthrough

15 May, 2002 by Pete Young

Australian research on sugars which stimulate stem cells to become bone tissue has resulted in a biological paste that promotes healing of fractures and breaks.


Sleep disorder treatments could help heart patients

15 May, 2002 by Daniella Goldberg

Cardiologists may be prescribing sleep disorder treatments to their patients in the next five years, according to reports from the 14th World Congress of Cardiology, held recently in Sydney.


Epilepsy discoveries expand Bionomics patent portfolio

14 May, 2002 by Tanya Hollis

South Australian genomics company Bionomics has expanded its portfolio of potential epilepsy drug targets with the filing of eight new patents.


Mass spec diagnostic developed for ovarian cancer

09 May, 2002 by Tanya Hollis

Mass spectrometry is helping Melbourne researchers develop a diagnostic test for the early detection of ovarian cancer.


Skin cancer device launched

08 May, 2002 by Daniella Goldberg

A device for the early detection of skin cancer has been launched by Sydney-based medical device company, Polartechnics.


Support for Prana Alzheimer's treatment

03 May, 2002 by Daniella Goldberg

Prana Biotechnology's theory for treating Alzheimer's disease with zinc-targeted drugs has won support from a paper published this week in the Proceedings of the National Academy of Science.


Starpharma STD gel in US tests

02 May, 2002 by Tanya Hollis

The US government is paying for tests of a Melbourne-developed microbicide gel on macaque monkeys.


Progen's cancer drug in trials

01 May, 2002 by Daniella Goldberg

Brisbane based Progen Industries has moved into Phase II clinical trials for their small molecule cancer drug PI-88.


Peplin researches pancreas

29 April, 2002 by Iain Scott

Peplin Biotech has broadened its research pipeline for anti-cancer drugs that target diseases of the pancreas.


AGRF participates in schizophrenia study

26 April, 2002 by Melissa Trudinger

The Australian Genome Research Facility (AGRF) has played a crucial role in a major international study on the genetic causes of schizophrenia.


Virax HIV trial to begin

24 April, 2002 by Tanya Hollis

Biopharmaceutical research and development group Virax Holdings has announced it has finished recruiting patients to its HIV treatment trial.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd